This study found 71.0% of DMD-treated patients continued their index DMD treatment for 17.0 ± 15.9 months without gaps exceeding 30 days, compared to an adherence rate of 62% to 64% among patients taking insulin for type 2 diabetes and 68% to 79% among patients taking oral medications for heart failure [33]. Here, INS is linked to type 2 diabetes mellitus.